Articles By Marcus Johnson
-
Experimental Brain Cancer Drug Shows Potential
3/25/2014
An experimental brain cancer drug has shown potential for treating patients with an aggressive form of the disease.
-
K-PAX Pharmaceuticals Develops Chronic Fatigue Syndrome Treatment
3/25/2014
A pharmaceutical company based out of Mill Valley has developed a treatment for chronic fatigue sydrome.
-
Cancer Institutes Are Increasingly Asking Big Pharma For Funding
3/10/2014
Budget cuts and other state imposed austerity measures have led to a lack of funding for many cancer research institutes. These institutes are increasingly turning to the pharmaceutical industry to get the funding that they need in order to continue their research.
-
i4Health Attempted To Access All Of UK's Patient Records
3/7/2014
An information firm associated with several pharmaceutical companies attempted to sign an agreement that would have given them direct access to the UK’s new medical database.
-
Nanoparticle Drug Delivery System Used To Target Cancer
3/6/2014
Researchers are working on a new cancer treatment that will allow doctors to directly target tumors in chemotherapy. The new treatment consists of a nanoparticle drug delivery system that uses laser light.
-
Health Advocates Lobbying FDA To Stop Sale Of Painkiller
3/5/2014
The FDA has already approved the release of Zogenix manufactured painkiller Zohydro. However, health advocates and doctors have begun a campaign to lobby the FDA to reconsider their course of action.
-
New Drugs Improve Learning In Children With Down Syndrome
3/5/2014
Drug makers such as Roche and Balance Therapeutics are working on new drugs that will improve the learning abilities of children with Down syndrome.
-
Pharmaceutical Companies Slash Spending On Promotional Speakers
3/5/2014
There is a growing trend of pharmaceutical companies operating in the US cutting promotional speaking payments.
-
Avastin Study Shows The Drug Doesn't Help Brain Cancer Patients
3/4/2014
Researchers had hoped the drug Avastin could be used to treat patients with brain cancer. A study published in The New England Journal Medicine has shown that the drug actually worsened a patient’s quality of life and decreased cognitive function.
-
Drug-Eluting Balloon Angioplasty Treatment Has Potential
2/26/2014
Drug-eluting balloons have shown promise as a treatment for restenosis in diabetic populations. In 40 percent of patients that get treatment for blocked arteries, those arteries will become obstructed once again.